Junlin Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 5
-
- Kidney Stones and Urolithiasis Treatments 8
- Ferroptosis and cancer prognosis 6
- Co-authors
- Shaogang Wang (19 shared papers)Qi‐Dong Xia (17 shared papers)Yang Xun (13 shared papers)Cong Li (10 shared papers)Jia Hu (8 shared papers)Xu Chen (7 shared papers)Yuchao Lu (3 shared papers)Tianxin Lin (5 shared papers)
In The Last Decade
Junlin Lu
33 papers receiving 752 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Cancer Research 164
- Pharmacology 73
- Complementary and alternative medicine 54
- Pulmonary and Respiratory Medicine 203
- Molecular Biology 325
Countries citing papers authored by Junlin Lu
This map shows the geographic impact of Junlin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlin Lu more than expected).
Fields of papers citing papers by Junlin Lu
This network shows the impact of papers produced by Junlin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlin Lu. The network helps show where Junlin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junlin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 172 | |
| 2 | NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer Hit paper breakdown → | 2023 | 128 |
| 3 | 2023 | 85 | |
| 4 | 2015 | 69 | |
| 5 | 2020 | 49 | |
| 6 | 2020 | 30 | |
| 7 | 2023 | 27 | |
| 8 | 2024 | 22 | |
| 9 | 2020 | 20 | |
| 10 | 2022 | 20 | |
| 11 | 2020 | 19 | |
| 12 | 2022 | 14 | |
| 13 | 2021 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2022 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 2022 | 6 | |
| 19 | 2025 | 5 | |
| 20 | 2021 | 5 |
About Junlin Lu
Junlin Lu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Complementary and Manual Therapy, Biotechnology and Urology, having authored 33 papers that have together received 760 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Kidney Stones and Urolithiasis Treatments (8 papers), Ferroptosis and cancer prognosis (6 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (5 papers), Pediatric Urology and Nephrology Studies (4 papers), Cancer Research and Treatments (3 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Cancer Research (164 citations), Pharmacology (73 citations), Complementary and alternative medicine (54 citations), Pulmonary and Respiratory Medicine (203 citations) and Molecular Biology (325 citations). Junlin Lu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Shaogang Wang, Qi‐Dong Xia, Yang Xun, Cong Li, Jia Hu, Xu Chen, Yuchao Lu, Tianxin Lin, Yuanyuan Yang and Ming Huang. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Frontiers in Medicine, Disease Markers, Scientific Reports and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.